Stay updated on CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 is added and the prior notices (including the funding status notice and Revision: v3.4.1) are removed. This reflects a platform update rather than any changes to trial data or study records.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide government funding notice and updated the record revision from v3.4.0 to v3.4.1, with no changes to core trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedUI updates include a glossary display toggle, color-coded highlights for additions and deletions, and the revision label changing to v3.4.0. These changes affect presentation only and do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedThese are minor metadata updates to the page history (added Revision: v3.3.4 and removed Revision: v3.3.3) and do not affect study data, status, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on this page. This reflects a minor site update and does not alter the trial data or records.SummaryDifference0.1%

Stay in the know with updates to CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page.